DR. STEPHEN M. ABO D.O.
Prescription History 1891717708
Internal Medicine - Hematology & Oncology in Newark, NJ
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. STEPHEN M. ABO D.O., an active Hematology & Oncology specialist practicing in Newark, NJ. Our medical registry currently tracks 35 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,343 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 250 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NJ PrescribersVs. NJ Avg |
|---|---|---|---|
| Anastrozole | 250 | $22.77 | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 250 Medicare prescriptions for Anastrozole, about 3.6 times the volume of the typical New Jersey prescriber of this medication (69.8). Medicare paid an average of $22.77 per fill, versus $22.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 723.3 30-Day Fills standardized to 30-day supplies 21,677 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 170 | $845.07▼ below NJ avg | ▲ More than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 170 Medicare prescriptions for Eliquis, about 1.8 times the volume of the typical New Jersey prescriber of this medication (94.2). Medicare paid an average of $845.07 per fill, versus $883.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 251 30-Day Fills standardized to 30-day supplies 7,530 Days of Medication total across all patients in 2024 | |||
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 108 | $29.52 | ▲ More than typical |
About Oxycodone-Acetaminophen: This combination medication is used to help relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2024, this provider wrote 108 Medicare prescriptions for Oxycodone-Acetaminophen, about 1.8 times the volume of the typical New Jersey prescriber of this medication (58.8). Medicare paid an average of $29.52 per fill, versus $19.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 110 30-Day Fills standardized to 30-day supplies 2,599 Days of Medication total across all patients in 2024 | |||
| XareltoRivaroxaban | 61 | $1,030.24 | ≈ Typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2024, this provider wrote 61 Medicare prescriptions for Xarelto, about 1.2 times the volume of the typical New Jersey prescriber of this medication (50.5). Medicare paid an average of $1,030.24 per fill, versus $964.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 119 30-Day Fills standardized to 30-day supplies 3,554 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 56 | $35.09 | ▲ More than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 56 Medicare prescriptions for Hydroxyurea, about 1.7 times the volume of the typical New Jersey prescriber of this medication (32.3). Medicare paid an average of $35.09 per fill, versus $26.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 144 30-Day Fills standardized to 30-day supplies 4,320 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 47 | $14.50▼ below NJ avg | ▲ More than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 47 Medicare prescriptions for Ondansetron Odt, about 2 times the volume of the typical New Jersey prescriber of this medication (23.8). Medicare paid an average of $14.50 per fill, versus $15.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 47 30-Day Fills standardized to 30-day supplies 672 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 43 | $13,449.92▼ below NJ avg | ▲ More than typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 43 Medicare prescriptions for Imbruvica, about 1.8 times the volume of the typical New Jersey prescriber of this medication (23.7). Medicare paid an average of $13,449.92 per fill, versus $15,070.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 43 30-Day Fills standardized to 30-day supplies 1,226 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 42 | $10.51▼ below NJ avg | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 42 Medicare prescriptions for Prochlorperazine Maleate, about 1.6 times the volume of the typical New Jersey prescriber of this medication (26.9). Medicare paid an average of $10.51 per fill, versus $12.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 42 30-Day Fills standardized to 30-day supplies 455 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 39 | $19.75 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 39 Medicare prescriptions for Gabapentin, about half the volume of the typical New Jersey prescriber of this medication (75.7). Medicare paid an average of $19.75 per fill, versus $14.21 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 89 30-Day Fills standardized to 30-day supplies 2,670 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 39 | $16,744.77 | ▲ More than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 39 Medicare prescriptions for Ibrance, about 1.4 times the volume of the typical New Jersey prescriber of this medication (27.4). Medicare paid an average of $16,744.77 per fill, versus $15,607.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,085 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 34 | $13.28▼ below NJ avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 34 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical New Jersey prescriber of this medication (64.7). Medicare paid an average of $13.28 per fill, versus $17.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 34 30-Day Fills standardized to 30-day supplies 678 Days of Medication total across all patients in 2024 | |||
| Prednisone | 33 | $2.94▼ below NJ avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 33 Medicare prescriptions for Prednisone, about 70% of the volume of the typical New Jersey prescriber of this medication (46.8). Medicare paid an average of $2.94 per fill, versus $4.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 37 30-Day Fills standardized to 30-day supplies 845 Days of Medication total across all patients in 2024 | |||
| Tramadol Hcl | 33 | $13.20 | ▼ Less than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2024, this provider wrote 33 Medicare prescriptions for Tramadol Hcl, about 72% of the volume of the typical New Jersey prescriber of this medication (45.9). Medicare paid an average of $13.20 per fill, versus $6.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 596 Days of Medication total across all patients in 2024 | |||
| Letrozole | 33 | $33.24 | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 33 Medicare prescriptions for Letrozole, about 67% of the volume of the typical New Jersey prescriber of this medication (49.2). Medicare paid an average of $33.24 per fill, versus $24.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96.8 30-Day Fills standardized to 30-day supplies 2,880 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 31 | $6.48▼ below NJ avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 31 Medicare prescriptions for Alendronate Sodium, about 70% of the volume of the typical New Jersey prescriber of this medication (44). Medicare paid an average of $6.48 per fill, versus $9.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 87.8 30-Day Fills standardized to 30-day supplies 2,634 Days of Medication total across all patients in 2024 | |||
| Warfarin Sodium | 31 | $11.88 | ≈ Typical |
About Warfarin Sodium: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a "blood thinner," but the more correct term is "anticoagulant." It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2024, this provider wrote 31 Medicare prescriptions for Warfarin Sodium, about 86% of the volume of the typical New Jersey prescriber of this medication (36). Medicare paid an average of $11.88 per fill, versus $9.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46 30-Day Fills standardized to 30-day supplies 1,355 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 30 | $15,159.73 | ≈ Typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 30 Medicare prescriptions for Calquence, about the same volume as the typical New Jersey prescriber of this medication (32.1). Medicare paid an average of $15,159.73 per fill, versus $14,066.84 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2024 | |||
| XtandiEnzalutamide | 28 | $14,359.51 | ≈ Typical |
About Xtandi: Enzalutamide is used to treat prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. An antineoplastic agent. In 2024, this provider wrote 28 Medicare prescriptions for Xtandi, about the same volume as the typical New Jersey prescriber of this medication (26.9). Medicare paid an average of $14,359.51 per fill, versus $13,483.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2024 | |||
| Abiraterone Acetate | 21 | $582.76▼ below NJ avg | ▼ Less than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2024, this provider wrote 21 Medicare prescriptions for Abiraterone Acetate, about a third of the volume of the typical New Jersey prescriber of this medication (57). Medicare paid an average of $582.76 per fill, versus $1,844.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Atorvastatin Calcium | 17 | $3.17▼ below NJ avg | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2024, this provider wrote 17 Medicare prescriptions for Atorvastatin Calcium, about 8% of the volume of the typical New Jersey prescriber of this medication (208.7). Medicare paid an average of $3.17 per fill, versus $11.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 43 30-Day Fills standardized to 30-day supplies 1,290 Days of Medication total across all patients in 2024 | |||
| Exemestane | 17 | $179.32 | ▼ Less than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 17 Medicare prescriptions for Exemestane, about half the volume of the typical New Jersey prescriber of this medication (33.8). Medicare paid an average of $179.32 per fill, versus $166.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2024 | |||
| KeytrudaPembrolizumab | 17 | $13,213.45 | ▼ Less than typical |
About Keytruda: Pembrolizumab is used to treat cancer. Show more ▾ It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies. In 2024, this provider wrote 17 Medicare prescriptions for Keytruda, about half the volume of the typical New Jersey prescriber of this medication (32.9). Medicare paid an average of $13,213.45 per fill, versus $11,478.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 357 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 15 | $10.35▼ below NJ avg | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 15 Medicare prescriptions for Omeprazole, about 19% of the volume of the typical New Jersey prescriber of this medication (77). Medicare paid an average of $10.35 per fill, versus $13.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
| SprycelDasatinib | 14 | $20,251.55 | ≈ Typical |
About Sprycel: This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. In 2024, this provider wrote 14 Medicare prescriptions for Sprycel, about the same volume as the typical New Jersey prescriber of this medication (15.1). Medicare paid an average of $20,251.55 per fill, versus $14,512.30 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| JakafiRuxolitinib Phosphate | 13 | $16,564.20▼ below NJ avg | ▼ Less than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2024, this provider wrote 13 Medicare prescriptions for Jakafi, about half the volume of the typical New Jersey prescriber of this medication (26.9). Medicare paid an average of $16,564.20 per fill, versus $16,657.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 13 | $87.39▼ below NJ avg | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 13 Medicare prescriptions for Imatinib Mesylate, about 66% of the volume of the typical New Jersey prescriber of this medication (19.8). Medicare paid an average of $87.39 per fill, versus $1,496.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
| RevlimidLenalidomide | 13 | $17,910.32 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 13 Medicare prescriptions for Revlimid, about a third of the volume of the typical New Jersey prescriber of this medication (33.4). Medicare paid an average of $17,910.32 per fill, versus $17,117.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 13 | $13.31 | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 13 Medicare prescriptions for Dexamethasone, about half the volume of the typical New Jersey prescriber of this medication (29.9). Medicare paid an average of $13.31 per fill, versus $11.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 453 Days of Medication total across all patients in 2024 | |||
| KisqaliRibociclib Succinate | 12 | $17,008.85 | ▼ Less than typical |
About Kisqali: Ribociclib is used to treat breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Inhibits both CDK4 and CDK6. In 2024, this provider wrote 12 Medicare prescriptions for Kisqali, about 64% of the volume of the typical New Jersey prescriber of this medication (18.7). Medicare paid an average of $17,008.85 per fill, versus $15,149.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 329 Days of Medication total across all patients in 2024 | |||
| Megestrol Acetate | 12 | $41.06▼ below NJ avg | ▼ Less than typical |
About Megestrol Acetate: Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Show more ▾ Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone. Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) In 2024, this provider wrote 12 Medicare prescriptions for Megestrol Acetate, about half the volume of the typical New Jersey prescriber of this medication (22.8). Medicare paid an average of $41.06 per fill, versus $72.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 14 30-Day Fills standardized to 30-day supplies 414 Days of Medication total across all patients in 2024 | |||
| Folic Acid | 12 | $3.68▼ below NJ avg | ▼ Less than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2024, this provider wrote 12 Medicare prescriptions for Folic Acid, about half the volume of the typical New Jersey prescriber of this medication (25.5). Medicare paid an average of $3.68 per fill, versus $8.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| TagrissoOsimertinib Mesylate | 12 | $17,247.38 | ▼ Less than typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. An EGFR tyrosine kinase inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Tagrisso, about half the volume of the typical New Jersey prescriber of this medication (27.7). Medicare paid an average of $17,247.38 per fill, versus $16,542.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| BrukinsaZanubrutinib | 12 | $7,480.27▼ below NJ avg | ▼ Less than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia. In 2024, this provider wrote 12 Medicare prescriptions for Brukinsa, about a third of the volume of the typical New Jersey prescriber of this medication (29.4). Medicare paid an average of $7,480.27 per fill, versus $13,682.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Hydrochlorothiazide | 11 | $4.48▼ below NJ avg | ▼ Less than typical |
About Hydrochlorothiazide: This medication is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/"water pills." It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet. A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. In 2024, this provider wrote 11 Medicare prescriptions for Hydrochlorothiazide, about 16% of the volume of the typical New Jersey prescriber of this medication (67.2). Medicare paid an average of $4.48 per fill, versus $4.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| Sandostatin Lar DepotOctreotide Acetate,mi-Spheres | 11 | $6,589.70 | ≈ Typical |
About Sandostatin Lar Depot: This medication is a long-acting form of octreotide. Show more ▾ Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (such as carcinoid tumors, vasoactive intestinal peptide tumors) that are found usually in the intestines and pancreas. The symptoms occur when these tumors make too much of certain natural substances (hormones). This medication works by blocking the production of these hormones. By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals. Octreotide is also used to treat a certain condition (acromegaly) that occurs when the body makes too much of a certain natural substance called growth hormone. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Octreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for these conditions. This medication is usually used with other treatment (such as surgery, radiation, other drugs). In 2024, this provider wrote 11 Medicare prescriptions for Sandostatin Lar Depot, about 79% of the volume of the typical New Jersey prescriber of this medication (13.9). Medicare paid an average of $6,589.70 per fill, versus $5,325.27 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. STEPHEN M. ABO D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Newark, NJ practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NJ prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
